Martin Quibell

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Martin Quibell is the founder and Chief Scientific Officer at Pedanius Therapeutics Ltd. which is founded in 2018.
He previously held positions as Director-Medicinal Chemistry at Acambis Plc, Vice President-Medicinal Chemistry at Amura Holdings Ltd. and Amura Therapeutics Ltd., and Principal at Incenta Ltd. Dr. Quibell earned a doctorate degree from the University of Birmingham in 1991 and an undergraduate degree from the University of Portsmouth.

Precedenti posizioni note di Martin Quibell

Società	Posizione	Fine
Incenta Ltd.	Corporate Officer/Principal	-
Amura Therapeutics Ltd.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Corporate Officer/Principal	-
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Martin Quibell

Formazione di Martin Quibell

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Martin Quibell

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	6
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Health Technology
University of Birmingham University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Portsmouth University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Health Technology
Amura Therapeutics Ltd.
Incenta Ltd.